Top Qs
Timeline
Chat
Perspective
Balipodect
Abandoned PDE10A inhibitor From Wikipedia, the free encyclopedia
Remove ads
Balipodect (INN , USAN ; developmental code name TAK-063) is a selective phosphodiesterase 10A (PDE10A) inhibitor which was under development by Takeda for the treatment of schizophrenia.[1][2][3]
Remove ads
It is active in animal models of antipsychotic-like activity, including inhibition of hyperlocomotion induced by the NMDA receptor antagonist dizocilpine (MK-801) or the dopamine releasing agent methamphetamine, inhibition of conditioned avoidance responses, and reversal of prepulse inhibition deficits.[4]
The drug reached phase 2 clinical trials for this indication but its development was discontinued.[1][2] It was reported to be poorly effective or ineffective for schizophrenia in clinical trials.[5][6][7]
Remove ads
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads